Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

8295	Companies
114847	Keywords
55290	Articles
62439	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 11/19/2024 at 15:35, 1 day 20 hours ago

Napo Therapeutics élu « Meilleur innovateur pharmaceutique de l'année - Europe »

Crofelemer Récompenses Maladies Rares Napo Thérapeutique Produits Pharmaceutiques Innovants
BRIEF

published on 11/19/2024 at 15:35, 1 day 20 hours ago

Napo Therapeutics Awarded "Best Pharmaceuticals Innovator of the Year - Europe"

Crofelemer Awards Rare Diseases Napo Therapeutics Innovative Pharmaceuticals
PRESS RELEASE

published on 11/19/2024 at 15:30, 1 day 20 hours ago

Jaguar Health Family Company Napo Therapeutics Named “Best Pharmaceuticals Innovator of the Year - Europe”
Jaguar Health's Napo Therapeutics awarded 'Best Pharmaceuticals Innovator of the Year - Europe' for expanding access to crofelemer in Europe for orphan and rare diseases. Partnering with Jaguar and Napo Pharmaceuticals for clinical studies

Crofelemer Jaguar Health Rare Diseases Orphan Diseases Napo Therapeutics
BRIEF

published on 11/13/2024 at 14:05, 7 days 21 hours ago

Jaguar Health annonce de solides résultats financiers au troisième trimestre 2024

Résultats Financiers Crofelemer Santé Jaguar 3e Trimestre 2024 Soins De Soutien Aux Personnes Atteintes De Cancer
BRIEF

published on 11/13/2024 at 14:05, 7 days 21 hours ago

Jaguar Health Reports Strong Q3 2024 Financial Performance

Financial Results Crofelemer Jaguar Health Q3 2024 Cancer Supportive Care
PRESS RELEASE

published on 11/13/2024 at 14:00, 7 days 21 hours ago

Jaguar Health Reports Third Quarter 2024 Financial Results
Jaguar Health, Inc. reports a 14% revenue increase in Q3 2024, introduces Gelclair commercial launch. Initiates Phase 2 trials and IIT studies. Hosts investor webcast on November 13

Revenue Increase Jaguar Health Q3 2024 Phase 2 Trials Gelclair
BRIEF

published on 11/11/2024 at 14:35, 9 days 21 hours ago

Jaguar Health to Discuss Q3 2024 Financials in Upcoming Investor Webcast

Napo Pharmaceuticals Crofelemer Investor Webcast Jaguar Health Q3 Financials
BRIEF

published on 11/11/2024 at 14:35, 9 days 21 hours ago

Jaguar Health discutera des résultats financiers du troisième trimestre 2024 lors d'un prochain webcast destiné aux investisseurs

Crofelemer Santé Jaguar Napo Pharmaceutique Résultats Financiers Du Troisième Trimestre Webcast Pour Les Investisseurs
PRESS RELEASE

published on 11/11/2024 at 14:30, 9 days 21 hours ago

Jaguar Health to Hold Investor Webcast Wednesday, November 13th at 8:30 AM Eastern Regarding Q3 2024 Financials & Corporate Updates
Jaguar Health, Inc. (NASDAQ:JAGX) to conduct investor webcast on November 13, 2024 at 8:30 a.m. Eastern to review Q3 2024 financials and provide corporate updates

Investor Webcast Jaguar Health Corporate Updates Q3 Financials NASDAQ:JAGX
BRIEF

published on 11/06/2024 at 16:05, 14 days 19 hours ago

FDA Renews Approval for Canalevia-CA1, Jaguar Health's Canine Diarrhea Drug

FDA Approval Veterinary Medicine Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea

Accesswire

Published on 11/21/2024 at 11:30, 11 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 1 hour 38 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour 41 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours 41 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 11 hours 6 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 11:30, 11 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 40 minutes ago

Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 11:00, 41 minutes ago

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 10:56, 44 minutes ago

ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 1 hour 11 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024

Les Echos

Published on 11/21/2024 at 06:58, 4 hours 43 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 43 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 43 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 15 hours 34 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 16 hours 21 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE